Digital Pathology at the South Bend Medical Foundation

Recently, the FDA approved the first digital pathology system for primary diagnosis of tissue biopsy specimens in the United States. For the past year, the South Bend Medical Foundation has been working to incorporate this technology into the laboratory to improve patient care for our community. At the end of 2016, the Medical Foundation acquired a high throughput, whole slide imaging device that allows scanning of traditional glass slides to produce a digital image. Images can be viewed from virtually anywhere and shared with pathologists, physicians and patients. We have been utilizing this technology for quality assurance in anatomic pathology and for education, including presenting cases at multispecialty tumor boards. The incorporation of digital pathology into the laboratory will improve efficiency in interpretation of anatomic pathology specimens and enable collaboration between the pathologist and the treating physician.

For more information about our digital pathology platform, please visit Leica Biosystems.


South Bend Medical Foundation assists Notre Dame graduate students

The South Bend Medical Foundation is working with PhD candidates Pavel Brodskiy and Qinfeng Wu from the Department of Chemical and Biomolecular Engineering at the University of Notre Dame to help them complete their research. Currently their studies focus on the genetic and mechanical mechanisms behind the regulation of tissue development, specifically calcium signaling in developing epithelial tissues in Drosophila. The students have hundreds of slides prepared that need to be scanned and digitized but only have the capability to scan a few slides at a time. The South Bend Medical Foundation has allowed them to use its high throughput digital slide scanner at no cost, enabling them to digitize hundreds of images at a time greatly reducing the amount of effort needed to complete their studies. The South Bend Medical Foundation is pleased to donate the use of this resource to Notre Dame and the scientific community.